{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:41:09Z","timestamp":1786372869089,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.2215\/cjn.06141108","type":"journal-article","created":{"date-parts":[[2009,8,20]],"date-time":"2009-08-20T21:53:15Z","timestamp":1250805195000},"page":"1465-1476","source":"Crossref","is-referenced-by-count":27,"title":["Simultaneous Control of PTH and Ca\u00d7P Is Sustained over Three Years of Treatment with Cinacalcet HCl"],"prefix":"10.2215","volume":"4","author":[{"given":"Stuart M.","family":"Sprague","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Evenepoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario P.","family":"Curzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred E.","family":"Husserl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Kopyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu Ren","family":"Sterling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Mix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20230601","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/j.jrn.2006.04.010","article-title":"Cinacalcet HCl: A novel treatment for secondary hyperparathyroidism caused by chronic kidney disease","volume":"16","author":"Torres","year":"2006","journal-title":"J Ren Nutr"},{"key":"R2-11-20230601","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1046\/j.1523-1755.2000.00945.x","article-title":"Vintage, nutritional status, and survival in hemodialysis patients","volume":"57","author":"Chertow","year":"2000","journal-title":"Kidney Int"},{"key":"R3-11-20230601","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"R4-11-20230601","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1523-1755.2005.00185.x","article-title":"Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study","volume":"67","author":"Young","year":"2005","journal-title":"Kidney Int"},{"key":"R5-11-20230601","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","article-title":"Association of elevated serum PO(4), Ca\u00d7PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","volume":"12","author":"Ganesh","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R6-11-20230601","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1523-1755.1999.00575.x","article-title":"Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure","volume":"56","author":"Rostand","year":"1999","journal-title":"Kidney Int"},{"key":"R7-11-20230601","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ncpendmet0394","article-title":"Drug insight: Vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease","volume":"3","author":"Brown","year":"2007","journal-title":"Nature Clinical Practice Endocrinology & Metabolism"},{"key":"R8-11-20230601","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1053\/ajkd.2001.22077","article-title":"Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1\u03b1-hydroxyvitamin D2) in dialysis patients with secondary hyperparathyroidism: A sequential comparison","volume":"37","author":"Maung","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"R9-11-20230601","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1093\/ndt\/16.10.1965","article-title":"Vitamin D analogues: How do they differ and what is their clinical role?","volume":"16","author":"Steddon","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"R10-11-20230601","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000073945","article-title":"Management of secondary hyperparathyroidism: The importance and the challenge of controlling parathyroid hormone levels without elevating calcium, phosphorus, and calcium-phosphorus produce","volume":"23","author":"Moe","year":"2003","journal-title":"Am J Nephrol"},{"key":"R11-11-20230601","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"key":"R12-11-20230601","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1525-139X.2005.18318.x","article-title":"How do calcimimetics fit into the management of parathyroid hormone, calcium, and phosphate disturbances in dialysis patients?","volume":"18","author":"Shahapuni","year":"2005","journal-title":"Semin Dial"},{"key":"R13-11-20230601","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1681\/ASN.2004060512","article-title":"Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: A randomized, double-blind, multicenter study","volume":"16","author":"Lindberg","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R14-11-20230601","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.ajkd.2006.01.015","article-title":"Meta-analysis of biochemical and patient-level effects of calcimimetic therapy","volume":"47","author":"Strippoli","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"R15-11-20230601","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1093\/ndt\/gfh966","article-title":"Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl","volume":"20","author":"Moe","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R17-11-20230601","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5414\/CNP68010","article-title":"Cinacalcet HCL (Sensipar\/Mimpara) is an effective chronic therapy for hemodialysis patients with secondary hyperparathyroidism","volume":"68","author":"Sterrett","year":"2007","journal-title":"Clin Nephrol"},{"key":"R18-11-20230601","first-page":"500A","article-title":"The magnitude of reductions in elevated serum calcium (Ca), Phosphorus (P), and CaxP levels with cinacalcet HCl is influenced by the dose of concurrent vitamin D sretols [Abstract F-PO753]","volume":"16","author":"Goodman","year":"2005","journal-title":"Am Soc Nephrol"},{"key":"R19-11-20230601","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1523-1755.2005.67139.x","article-title":"Achieving NKF-K\/DOQI bone metabolism and disease treatment goals with cinacalcet HCl","volume":"67","author":"Moe","year":"2005","journal-title":"Kidney Int"},{"key":"R20-11-20230601","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000168465","article-title":"Long-term suppression of secondary hyperparathyroidism by intravenous 1alpha-hydroxy vitamin D3 in patients on chronic hemodialysis","volume":"12","author":"Brandi","year":"1992","journal-title":"Am J Nephrology"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-200909000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:38:56Z","timestamp":1786369136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-200909000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.06141108","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}